Unity Biotechnology
ClosedSouth San Francisco, United States · Founded 2011 · $116.0M raised
- Headquarters
- South San Francisco, California
- Founded
- 2011
- Website
- unitybiotechnology.com
- Total Funding
- $116.0M
- Last Round
- $116.0M Venture RoundOct 2016
- Rounds
- 1
About
Unity Biotechnology was a clinical-stage biotechnology company developing senolytic medicines that selectively eliminate senescent cells to treat age-related diseases, with a primary focus on ophthalmologic conditions including diabetic macular edema. The company conducted clinical trials for its lead candidate UBX1325. Unity ceased operations in 2025.
Summary
Unity Biotechnology is a Biotech company based in South San Francisco, United States, founded in 2011. It has raised $116.0M in total across 1 round, most recently a $116.0M Venture Round round in Oct 2016.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Oct 2016
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/unity-biotechnology"><img src="https://indexed.vc/api/badge/company/unity-biotechnology" alt="Unity Biotechnology on Indexed.vc" width="260" height="76" /></a>